Exopharm Ltd: Change of Director's Interest Notice - MD
Exopharm Ltd: Change of Director's Interest Notice - CB
Exopharm Ltd: Final Director's Interest Notice - ID
Exopharm Ltd: Quarterly Activities Report and Appendix 4C
Exopharm Ltd: Despatch of Offer Document
Exopharm Ltd: Addendum to the Notice of Meeting
Exopharm Ltd: Tryp Therapeutics Securityholder Approval
Exopharm Ltd: EX1 signs binding agreement to acquire Tryp Therapeutics
Exopharm Ltd: Quarterly Activities Report and Appendix 4C
Exopharm Ltd: Change of Director's Interest Notice - MD
Exopharm Ltd: Change of Director's Interest Notice - CB
Exopharm Ltd: Correction to Director Interest Notices
Exopharm Ltd: 2023 AGM Chair Address
Exopharm Ltd: Quarterly Activities Report and Appendix 4C
Exopharm Ltd: Suspension from Quotation
Exopharm Ltd: Financial improvements continue
Exopharm Ltd: Appendix 4G and Corporate Governance Statement for FY2023
Exopharm Ltd: Quarterly Activities Report and Appendix 4C
Exopharm Ltd: Initial Director's Interest Notice - MD
Exopharm Ltd: Change of Director's Interest Notice - CB
No Data